ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

11,988.00
-38.00 (-0.32%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -38.00 -0.32% 11,988.00 12,014.00 12,018.00 12,144.00 11,882.00 12,070.00 2,340,814 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.28 186.27B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,026p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,210.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £186.27 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.28.

Astrazeneca Share Discussion Threads

Showing 4551 to 4573 of 6150 messages
Chat Pages: Latest  186  185  184  183  182  181  180  179  178  177  176  175  Older
DateSubjectAuthorDiscuss
23/3/2021
02:13
=== A Prion Disease Development that just might lead to finding a cure =====

Well done to the guys at Inperial College London



With this information, they also worked with the team at the University of Zurich who were able to produce antibodies that could target the mechanism. In a proof-of-concept study in the test tube, they were successfully able to block prions transitioning from the normal to the pathogenic form.

This is a GIANT step forwards

Molecule/pairs small enough to pass through the blood brain barrier will imo have to be found

Perhaps using patented techniques that TIE TOGETHER the molecules that are needed for the job

buywell3
22/3/2021
19:25
FF,

No, not as the share price has gone through £73 with some large II AT buys at £73.44 after the close, appears little or no resistance until £75 and won't take much to break this level.
Looking like a strong finish over the pond.

beckers2008
22/3/2021
18:21
I had zero reaction but I have had Covid. So no shock to my immune system. I you get a reaction you probably have not had covid.
tonsil
22/3/2021
17:46
#4468 Maybe even quicker than that. Jab at lunchtime, I then had chills that evening and slightly feverish night, but felt fine around a day or so later. And compared to the alternative, I'll gladly have that slight inconvenience.
bluemango
22/3/2021
17:42
Still think this is a bloody good downward channel trade.
freddie ferret
22/3/2021
17:25
Philanderer, you know it makes sense. Just be prepared for the reaction and the knowledge that in a few days you'll feel fine :-)
davius
22/3/2021
13:31
Hopefully that puts the recent salacious nonsense to bed.
essentialinvestor
22/3/2021
11:01
Those 79% and 100% stats have swayed it for me . Just booked in for a friday morning jab.
philanderer
22/3/2021
10:47
Indeed. It would not exactly help relations with our continental neighbours if it turns out that over-cautiousness and incompetence on their part, caused us further delays in opening up our own freedoms again.

Having said that, a majority vaccinated population in the UK should, regardless of incompetence abroad, allow us some resumption of normality - whatever they continue to bring in via international travel.

bluemango
22/3/2021
10:44
That's great news. The EU has been a complete embarrassment with this and really shown their true colours.First they stop using it when there was no evidence it was causing the blood clots then they try and block our supply.Despite being given the all clear Spain are not starting using it again till Wednesday more days lost.No wonder the EU is so far behind with only around 12% vaccinated compared with 50% here.
tim 3
22/3/2021
10:12
This is the important bit.."100% efficacy at preventing severe disease and hospitalisation.."


Edit - you got there before me blue.

essentialinvestor
22/3/2021
09:11
In theory AstraZeneca could be selling the vaccine for a profit from as early as about 13 weeks' time:



Surely by then it can be declared the 'Pandemic's over' in the UK, if current trends continue. The doubt is whether you could state the same globally.

bluemango
22/3/2021
08:54
"... 100% effective at preventing people from falling seriously ill"

Awesome result, and the Holy Grail for getting some kind of normality back in our lives. One thing which we can all agree on, that we all want.

(Speaking as someone who hates the loathsome, dehumanising facemasks with a passion)

bluemango
22/3/2021
08:22
Given that the trial reported today is US-based and that there wasn’t a single episode of CSVT in the vaccinated cohort, I would expect US approval to be swift. They have a stockpile available and a political imperative to use it.

CSVT looks like a genuine but very rare complication. It has been described after the Pfizer and Moderna Vaccs as well. It does not alter the balance of benefit to the population as a whole, which is overwhelmingly positive.

Driving a car for an hour has a mortality of roughly 1 in a million. Buses are safer. Who’s taking the bus to work today?

caradog
22/3/2021
08:01
Covid causes increased blood clotting-and its common in Covid cases not rare.
tonsil
22/3/2021
07:51
.. and % 100 effective in reducing hospitalisation severe illness and death US should approve within the next 6-8 weeks
panshanger1
22/3/2021
07:46
Corporate Highlights

Kingfisher said that sales rose to £12.3 billion for the year, from £11.5 billion, while operating profit hit £946 million, versus £717 million a year earlier.

The trial of AstraZeneca's Covid vaccine in the US has demonstrated 79% efficiency in combating the virus, with no increased risk of blood clots.

Centamin's 2020 revenue rose 27% to $828 million, while pre-tax profit soared 82% to $314 million.

nick100
22/3/2021
07:11
Correlation does not imply causation!
t999mrb
22/3/2021
04:58
The son of a friend of mine got the AZ vaccine last week. He took a severe allergic reaction and now has a blood clot in his brain. The young man is in his early 30s. There does seem to be something with AZ and blood clots. Why is it not happening with the other vaccines?
volsung
21/3/2021
23:22
And sadly, just as likely to have died from blood clots had they caught COVID due to that strong immune response.
goodgrief
21/3/2021
20:19
RIP Jose Baselga.
gregb
21/3/2021
17:00
People were right to protest on the weekend and as the weather warms up over the Spring and Summer months this movement will only strengthen.

Can't keep the country in lockdown with such low numbers.
What happens if deaths hit 10 next weekend??

Israel is down to just 3 deaths today - yes THREE; it was 9 yesterday.
It has re-opened its economy btw.

Again no justification for destroying the economy here with such harsh lockdowns once vaccines have taken effect.

justiceforthemany
21/3/2021
16:57
& just 33 UK deaths. A 98% drop from the peak.
Boris how can you justify such a harsh lockdown when this is not even 2% of the daily UK death toll of 2,000?

& at a time when Covid patients are now taking up just 2.8% of total NHS beds?

justiceforthemany
Chat Pages: Latest  186  185  184  183  182  181  180  179  178  177  176  175  Older

Your Recent History

Delayed Upgrade Clock